Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P <sub>1</sub> ‐selective modulation-Reference-Cited by-同舟云学术

Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P ₁ ‐selective modulation

Published:2022-01-05 Issue:2 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Kihara Yasuyuki¹,Jonnalagadda Deepa¹,Zhu Yunjiao¹,Ray Manisha¹,Ngo Tony¹,Palmer Carter¹²,Rivera Richard¹,Chun Jerold¹

Affiliation:

1. Sanford Burnham Prebys Medical Discovery Institute Translational Neuroscience Initiative La Jolla California USA

2. Biomedical Sciences Program University of California, San Diego La Jolla California USA

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202101531R

Reference67 articles.

1. Lysophospholipid Receptors: Signaling and Biology

2. Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders

3. Lysophospholipid receptor nomenclature review: IUPHAR Review 8

4. Sphingosine 1‐phosphate receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects;Chun J;Drugs,2020

5. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Localization of S1P₁Receptor Signaling in the rat, mouse and human Central Nervous System;2024-01-31

2. The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation;The FASEB Journal;2024-01-20

3. Direct Binding Methods to Measure Receptor–Ligand Interactions;The Journal of Physical Chemistry B;2023-12-22

4. Bioavailable central nervous system disease-modifying therapies for multiple sclerosis;Frontiers in Immunology;2023-11-29

5. Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells;International Journal of Molecular Sciences;2023-10-27